Chronic lower back pain (CLBP) — defined as pain in the lumbar region persisting for 12 weeks or more — is the leading cause of disability globally and one of the most common reasons for GP and specialist consultations in SA. It ranges from mild, intermittent aching managed conservatively to severe, functionally incapacitating pain requiring interventional procedures or surgery. Medical aid coverage for CLBP is generous in some areas — particularly for inpatient surgery — but poorly structured for the outpatient chronic management that benefits most patients most of the time. Understanding where the coverage is strongest, and where it fails, is essential for patients managing this condition long-term.
Classification: Why It Matters for Coverage
By cause: - Non-specific CLBP: No identifiable structural cause on imaging — the most common category (approximately 85% of CLBP). Managed conservatively; surgery is generally not beneficial. - Specific CLBP: Identifiable cause — lumbar disc herniation, lumbar spinal stenosis, spondylolisthesis, degenerative disc disease. May benefit from targeted intervention or surgery. - Radiculopathy: Nerve root compression causing leg pain (sciatica) in a dermatomal distribution. A herniated disc pressing on L4, L5, or S1 nerve roots is the most common cause. - Cauda equina syndrome: Compression of the cauda equina nerve roots causing bilateral leg weakness, saddle anaesthesia, and bladder/bowel dysfunction. This is a neurosurgical emergency requiring immediate decompression.
Why classification matters: Non-specific CLBP is managed conservatively (physiotherapy, exercise, psychological intervention, analgesia). Surgical intervention for non-specific CLBP is generally not indicated and not covered under any meaningful PMB or non-PMB standard. Specific CLBP with neurological compromise (particularly cauda equina syndrome) is a PMB emergency requiring immediate surgery. This distinction drives the entire coverage conversation.
Coverage Framework
Medications: Funded through MSA/standard benefits. Not CDL; not PMB for chronic management.
Physiotherapy: Funded through physiotherapy benefit (typically 10–20 sessions/year). Standard annual limit is frequently exhausted for CLBP requiring ongoing rehabilitation.
Psychologist: Pain psychology (CBT) is first-line evidence-based treatment for CLBP. Funded through mental health outpatient benefit.
Pain specialist procedures: Epidural steroid injections, facet joint injections, medial branch blocks, radiofrequency ablation (RFA) — covered as specialist procedures; shortfalls apply.
Spinal surgery: Funded under in-hospital benefit. No PMB minimum standard for elective back surgery. Neurosurgeon and anaesthetist shortfalls are significant.
Cauda equina syndrome: PMB emergency. Surgery covered immediately; no authorisation wait.
Analgesics: The Medication Landscape
Back pain analgesia follows a stepped approach:
First-line — simple analgesics: Paracetamol (acetaminophen) — safest for long-term use; modest efficacy for CLBP. Monthly cost: R80–R150.
First-line — NSAIDs: Ibuprofen, naproxen, diclofenac — effective for inflammatory component; most effective for acute episodes within CLBP. Significant GI and cardiovascular risks with long-term use. Topical diclofenac (Voltaren gel) safer for local application with lower systemic risk. Monthly cost: R150–R300.
Second-line — muscle relaxants: Cyclobenzaprine, baclofen — for muscle spasm component. Monthly cost: R200–R350. Short-term use preferred.
Second-line — antidepressant analgesics: Amitriptyline (low dose), duloxetine (Cymbalta) — for neuropathic or centrally sensitised pain. Monthly cost: R200–R700.
Second-line — neuropathic agents: Pregabalin (Lyrica) — for radicular/neuropathic pain. Monthly cost: R700–R900. Schedule 5 in SA.
Opioids — last resort: Tramadol (weak opioid) for moderate-severe pain: short-term use; dependence risk. Codeine-containing preparations are commonly self-medicated but carry dependence risk. Strong opioids are not appropriate for non-specific CLBP and are not a long-term solution for any CLBP.
Physiotherapy and Active Rehabilitation: The Evidence Base
For CLBP, active exercise-based rehabilitation is strongly superior to passive physiotherapy (massage, ultrasound, TENS alone). The evidence base strongly supports: - Supervised graduated exercise programmes - Core stabilisation and strengthening - Aerobic exercise (walking, swimming, cycling) - Graded activity — systematic increase in activity levels despite pain
Most plan physiotherapy benefits (10–20 sessions/year) are inadequate for a condition requiring an ongoing, progressive exercise programme. The same strategies used for fibromyalgia and bronchiectasis apply: use the benefit for supervised programme design and assessment, then transition to an independent home programme.
Interventional Procedures
Epidural steroid injections (ESI): Cortisone injected into the epidural space under fluoroscopic guidance. Most useful for radicular pain (sciatica). Usually 1–3 injections per pain episode. Cost per injection (facility + pain specialist shortfall): R5,000–R15,000. Requires pre-authorisation; shortfall from pain specialist/anaesthesiologist is the primary out-of-pocket exposure.
Facet joint injections / medial branch blocks: Diagnostic and therapeutic injections for facet-mediated back pain. Cost: R3,000–R8,000 per session.
Radiofrequency ablation (RFA): Thermal disruption of medial branch nerves supplying facet joints. Longer-lasting than injections; cost: R15,000–R40,000 per session (facility + specialist).
Spinal Surgery: The High-Cost Event
For specific CLBP with structural pathology: - Microdiscectomy / discectomy: Surgical decompression of a herniated disc pressing on a nerve root. Usually day case or overnight stay. Total cost before shortfall: R40,000–R80,000. Neurosurgeon shortfall: R30,000–R80,000. - Spinal fusion: For instability, spondylolisthesis, recurrent disc disease. Longer procedure; hardware implanted. Total cost: R100,000–R200,000+. Implant cost alone: R40,000–R80,000.
Annual Cost Estimates
| Scenario | Estimated Annual Cost |
|---|---|
| Conservative management — physio + analgesics + GP | R8,000 – R25,000 |
| Interventional — ESI + pain specialist visits | R30,000 – R70,000 |
| Surgical year — microdiscectomy | R80,000 – R150,000 |
| Surgical year — spinal fusion | R120,000 – R250,000+ |
Gap Cover Relevance: High
Spinal surgery and interventional pain procedures both generate significant specialist shortfalls. Gap cover with OPL ~R220,000/year is strongly recommended for any patient with CLBP where surgery or interventional management is being considered.
Talk to Eldon
See which plans pay for chronic lower back pain →
This page is general information about medical schemes. It is not medical advice: speak to a healthcare professional about your own treatment. Medical aid and gap cover advice is given by Eldon de Waal, a Supervised Representative of Approach Administration (FSP 23579).